The Department of Pharmacology and Cancer Biology was created to foster collaborative interactions between scientists with different, though complementary, research interests and expertise. The primary goal in developing such an interdisciplinary department was to create an environment where rigorous scientific debate and discourse between researchers with different perspectives would create a stimulating and productive intellectual environment for faculty and trainees alike. As you browse through the research descriptions of our faculty and appreciate the breadth and significance of their scientific achievements, it should become clear that this experiment was a tremendous success. Research projects address a myriad of important scientific questions relevant to cancer, metabolism, nervous system function, drugs of abuse, and environmental toxicants. However, one unifying theme that has emerged in the department is cell signaling and the use of pharmacological approaches to define the key regulatory steps in relevant pathways that may be amenable to pharmaceutical exploitation or whose dysregulation may be involved in the pathogenesis of disease. It is a privilege to welcome you to our website and we encourage you to learn more about the opportunities in research, training, and education offered by this exciting and dynamic department.
Donald P. McDonnell, Ph.D.
Professor and Chairman


  • Wednesday, October 7, 2015 at 12:00 pm

  • Andrea Ventura, MD, PhD, Memorial Sloan Kettering Cancer Center
  • “miRNAs and CRISPR, from biology to technology”
  • 103 Bryan Research
  • Thursday, October 8, 2015 at 12:00 pm

  • Gabriel De Leon (Advisor: Duane Mitchell)
  • “Immunologic Targeting and Biologic Underpinnings of Human Cytomegalovirus in Glioblastoma"
  • 001 MSRB
  • Wednesday, October 14, 2015 at 12:00 pm

  • Karen Adelman, PhD, NIEHS
  • “Controlling elongation of coding and non-coding RNAs”
  • 103 Bryan Research
  • Wednesday, October 21, 2015 at 12:00 pm

  • Bruce Edgar, PhD, Huntsman Cancer Institute
  • “Regenerative and tumorigenic growth in the Drosophila intestine”
  • 103 Bryan Research
  • Wednesday, October 28, 2015 at 12:00 pm

  • Peter Jackson, PhD, Stanford University School of Medicine
  • “IGF1 and GPCR signaling in primary cilia determines asymmetric mesenchymal stem cell division”
  • 103 Bryan Research
  • Wednesday, November 11, 2015 at 12:00 pm

  • Chad Dickey, PhD, University of South Florida
  • “Drowsy chaperones: How the protein quality control system enables diseases of aging”
  • 103 Bryan Research
[ All Upcoming Seminars ]

© 2012 Pharmacology and Cancer Biology. Duke University School of Medicine. Site design: Academic Web Pages